RFK Jr. Clearing obstacle to head HHS. Nomination is black box.

Robert F. Kennedy Jr. Cleared a Key Linner Tuesday after Senat’s Finance Committee voted along party lines to send his nomination to the full chamber.

The panel voted 14 to 13 in favor of Kennedy’s nomination. Kennedy or RFK Jr. Won a yes vote from Senator Bill Cassidy, R-La., A doctor and panel’s chair who had expressed concern for Kennedy’s former anti-vaccine attitude.

Arily
X

Playing now
The weight loss medicine is hot. What medical stock wins the battle for supremacy?

In a post for social media platform x, Cassidy said he had “very intense conversations” with RFK Jr.

“With the serious obligations I have received from the administration and the opportunity to make progress with the questions we agree on as healthy foods and a pro-American agenda, I will vote yes,” he said prior to the vote.

The news is potentially negative for biotech companies that develop vaccines. Moderna (Mrna) The stock dropped more than 3% to 35.18. BionTech (BNTX) Equity lost 1.6% and traded near 117.88. Pfizer (PFE) Shares turned from an early gain of a fourth -quarter battle that fell 1.2% to 25.88. GSK (GSK) Shares dipped a fraction.

“We see this evolving regulatory environment as negative for producers of primary care – both on a basic and mood basis (MRNA most vulnerable) – and netto positively for rare/serious illness companies,” Leerink Partner’s analyst Mani Foroohar said in a report.

RFK Jr. and vaccines

RFK Jr. have said he will not “take vaccines away from someone.”

But he still can’t escape his former anti-vaccine attitude, web Golinkin says. Golinkin has been leading six companies over the past 35 years, including FastMed and Rediclinic.

“Although it seems that he has tried to distance himself from (his previous comments), it is pretty inevitable,” Golinkin told Investor’s Business Daily. “Parents’ skepticism about vaccines could be a huge public health problem. He says he is not anti-vaccine, he says he is pro-security. But it seems that he is really an antiscience and that can be a huge problem. ”

Golinkin expects RFK Jr. Dig deeper into the matters of the vaccines.

“I don’t think he will find what he is looking for,” he said. “But I think it’s naive to think he won’t try.”

Vaccine development is fast

In fact, there is little kennedy can do to prevent vaccine development.

Authorities at Food and Drug Administration are responsible for evaluating the security and effectiveness of drugs, vaccines and medical devices. If confirmed, Kennedy will lead up to the Department of Health and Human Services that oversees the FDA. But he does not look at applications for new vaccine approvals.

Doug Drysdale, CEO of Cybin (Cybn), say some vaccines need to be developed quickly. Companies renew their flu and covid vaccines annually to keep up with viral mutations.

“He has publicly told that regardless of his view of some vaccines, he will not stop people getting them if they want them,” he told IBD. “And I can’t see the FDA or who or the UN or any elite public politics; public health organ will stop developing or supporting the development of vaccines.”

‘Energy and enthusiasm’

Drysdale expects RFK Jr. have “energy and enthusiasm” to improve some processes.

It is an advantage for his biotech company. Cybin develops synthetic modified versions of psychedelic drugs. The company tests the active ingredients found in mushrooms and Ayahuasca to treat depression and anxiety respectively. Its antidepressant is in phase 3 test.

Kennedy has spoken publicly for psychedelic drugs, including about his son’s experience with hallucinogen ayahuasca.

“When I heard about him being nominated, I saw it just as something that is not negative,” said Sprinsdale. “He won’t put the brakes on this research. Now there’s the potential he could help it. The more I hear him talk about this, the more positive I feel.”

However, cybin stock has generally fallen since the middle of 2021. Shares have a low relative strength assessment of 18 out of a best possible 99. This means that the biotech share ranks in the lower fifth of all shares when it comes to 12-month performance, according to IBD Digital.

RFK Jr. is unconventional

Dr. Yan Katnelson, a heart surgeon and CEO of USA Clinics Group, is similarly positive on RFK Jr.’s nomination. He recognizes Kennedy is somewhat unconventional as a candidate.

“He is not a doctor, he does not have a license, he will not change things, he will not prescribe medicine,” Katsnelson said in an interview.

Instead, RFK Jr. ask questions. He will not trust decades old information, Katsnelson said.

Where Katnelson is particularly enthusiastic, however, is in prevention. Kennedy has made his attitude towards ultra-processed foods well-known. During the first confirmation hearing, Kennedy said he would like to “resolve our food supply.”

“We meet patients too late,” Katsnelson said. “He will meet the problem before it arrives. Make foods healthier. Do what we can to prevent illness. It goes against the medicine.

You also like:

Pfizers Covide products ran its fourth quarter up. But is it sustainable?

Merck Stock Plummets 10% As Gardasil Dynamics, 2025 Guide Road on Shares

Find the best long term investments with IBD long -term leaders

Trade in Opportunities: How To Begin To Use Options How To Manage Risk

See shares on the list of managers near a purchase point